Brain metastasis is a terrifying complication of advanced breast cancer, with a grim prognosis and few treatment options. The cancer's spread to the brain is often undetected until patients start to develop symptoms such as seizures, headaches, and trouble thinking. Scientists hope a better understanding of the molecular events that regulate brain metastasis will lead to earlier diagnosis and improved therapies.
Using cell models, the researchers found that breast cancer cells harness a protein called alphaB-crystallin to help them stick to endothelial cells that line the small blood vessels in the brain. In addition, this protein enhances the penetration of breast cancer cells through the blood-brain barrier, which normally prevents cells and many molecules from entering the brain. Once in the brain, the breast cancer cells are able to form metastases.
The study, published in Clinical Cancer Research, and featured on the journal cover, was led by Dr. Vincent Cryns, professor of medicine at the University of Wisconsin School of Medicine and Public Health and a member of the University of Wisconsin Carbone Cancer Center.
Cryns and his colleagues also developed new mouse models of breast-cancer brain metastasis that mimic many features of the human disease. They found that reducing the expression of alphaB-crystallin in breast cancer cells hindered the cells' ability to form brain metastases in mice.
"These observations in our mouse models suggest that alphaB-crystallin may be a promising drug target that should be explored further," said Cryns. "Although there are no drug inhibitors of this protein currently, we are actively pursuing studies to identify drugs that might reduce the expression of the protein or block its effects," he added.
In addition, by examining tissue from breast-cancer patients who developed brain metastasis, the investigators discovered that women with breast tumors that expressed alphaB-crystallin had a shorter survival than women with breast tumors that did not express this protein. These studies were conducted in collaboration with researchers at the University of North Carolina at Chapel Hill, Duke University and other institutions.
Furthermore, the team found breast tumors that expressed alphaB-crystallin were more likely to be triple-negative breast cancers—an aggressive type of cancer, which lacks three receptors (estrogen receptor, progesterone receptor and HER-2) expressed in other types of breast cancer. Triple-negative breast cancers are known to have a high incidence of brain metastasis.
"Our findings suggest that alphaB-crystallin may contribute to the tendency of triple-negative breast cancers to metastasize to the brain and to their poor prognosis," said Cryns. Yet, he cautioned these findings need to be validated in additional studies.
The research was supported by grants from the Breast Cancer Research Foundation, the National Institutes of Health, Susan G. Komen, and the Cancer and Leukemia Group B.
Lisa Brunette | EurekAlert!
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy